Differential gene expression in CD8+ cells exhibiting noncytotoxic anti-HIV activity

Virology

Volumn 311, Issue 2, 2003, Pages 400-409

  Diaz, Leyla S ^a   Stone, Mars R ^a   Mackewicz, Carl E ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD8+ cell noncytotoxic antiviral response; Gene expression; HIV replication; Reverse transcriptase; Suppressive subtractive hybridization

Indexed keywords

CD8 ANTIGEN;

ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOZYGOTIC TWINS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS REPLICATION;

EID: 0038045729     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00177-6     Document Type: Article

References (40)

1. + cells from HIV-2-infected baboons control HIV replication. AIDS. 11:1997;737-746.
2. + T cells evidence for a soluble inhibitor . J. Immunol. 144:1990;2961-2966.
3. + T cell number in untreated asymptomatic HIV-infected individuals. Blood. 99:2002;4225-4227.
4. + cell depletion or CMV infection. Clin. Immunol. Immunopathol. 65:1992;227-233.
5. + T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription a novel antiviral mechanism . AIDS Res. Hum. Retroviruses. 9:1993;1079-1086.
6. Choi I.S., Hokanson R., Collisson E.W. Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication. J. Virol. 74:(2):2000;676-683.
7. Chun T.W., Justement J.S., Moir S., Hallahan C.W., Ehler L.A., Liu S., McLaughlin M., Dybul M., Mican J.M., Fauci A.S. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells implications for the development of therapeutic strategies . Proc. Natl. Acad. Sci. USA. 98:(1):2001;253-258.
8. Cohen S., Dadi H., Shaoul E., Sharfe N., Roifman C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood. 93:(6):1999;2013-2024.
9. Copeland K.F.T., McKay P.J., Rosenthal K.L. Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Res. Hum. Retroviruses. 11:1995;1321-1326.
10. Dahl C.A., Schall R.P., He H.L., Cairns J.S. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 148:(2):1992;597-603.
11. Diatchenko L., Lau Y.F., Campbell A.P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E.D., Siebert P.D. Suppression subtractive hybridization a method for generating differentially regulated or tissue-specific cDNA probes and libraries . Proc. Natl. Acad. Sci. USA. 93:(12):1996;6025-6030.
12. Ennen J., Findeklee H., Dittmar M.T., Norley S., Ernst M., Kurth R. CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc. Nat. Acad. Sci. USA. 91:1994;7207-7211.
13. Gomez A.M., Smaill F.M., Rosenthal K.L. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Clin. Exp. Immunol. 97:1994;68-75.
14. Greco G., Mackewicz C., Levy J.A. Sensitivity of HIV infection to various α, β, and γ chemokines. J. Gen. Virol. 80:1999;2369-2373.
15. Hoffman A.D., Banapour B., Levy J.A. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology. 147:1985;326-335.
16. Kannagi M., Chalifoux L.V., Lord C.I., Letvin N.L. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. J. Immunol. 140:1988;2237-2242.
17. + T cell suppression of syncytia-inducing strains of HIV-1. Proc. Natl. Acad. Sci. USA. 94:(18):1997;9842-9847.
18. Landay A.L., Schade S.Z., Takefman D.M., Kuhns M.C., McNamara A.L., Rosen R.L., Kessler H.A., Spear G.T. Detection of HIV-1 provirus in bronchoalveolar lavage cells by polymerase chain reaction. J. Acquir. Immune Defic. Syndr. 6:1993;171-175.
19. Levy J.A., Mackewicz C.E., Barker E. Controlling HIV pathogenesis the role of noncytotoxic anti-HIV activity of CD8+ cells . Immunol. Today. 17:1996;217-224.
20. Levy J.A., Tobler L.H., McHugh T.M., Casavant C.H., Stites D.P. Long-term cultivation of T cell subsets from patients with acquired immune deficiency syndrome. Clin. Immunol. Immunopathol. 35:1985;328-336.
21. Lisitsyn N.A. Representational difference analysis finding the differences between genomes . Trends Genet. 11:(8):1995;303-307.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:(4):2001;402-408.
23. MacGregor A.J., Snieder H., Schork N.J., Spector T.D. Twins. Novel uses to study complex traits and genetic diseases. Trends Genet. 16:(3):2000;131-134.
24. Mackewicz C.E., Barker E., Greco G., Reyes-Teran G., Levy J.A. Do β-chemokines have clinical relevance in HIV infection? J. Clin. Invest. 100:1997;921-930.
25. Mackewicz C.E., Barker E., Levy J.A. Role of β-chemokines in suppressing HIV replication. Science. 274:1996;1393-1395.
26. Mackewicz C.E., Blackbourn D.J., Levy J.A. CD8+ cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA. 92:1995;2308-2312.
27. Mackewicz C.E., Garovoy M.R., Levy J.A. HLA compatibility requirements for CD8+ T-cell-mediated suppression of human immunodeficiency virus replication. J. Virol. 72:(12):1998;10165-10170.
28. Mackewicz C.E., Ortega H., Levy J.A. Effect of cytokines on HIV replication in CD4+ lymphocytes lack of identity with the CD8+ cell antiviral factor . Cell. Immunol. 153:1994;329-343.
29. Mackewicz C.E., Ortega H.W., Levy J.A. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 87:1991;1462-1466.
30. Marie-Cardine A., Kirchgessner H., Bruyns E., Shevchenko A., Mann M., Autschbach F., Ratnofsky S., Meuer S., Schraven B. SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation. J. Exp. Med. 189:(8):1999;1181-1194.
31. Medley Q.G., Kedersha N., O'Brien S., Tian Q., Schlossman S.F., Streuli M., Anderson P. Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc. Natl. Acad. Sci. USA. 93:(2):1996;685-689.
32. + cells from SIV/SMM infected scropositive clinically asymptomatic sooty mangabeys. J. Med. Primatol. 19:1990;239-249.
33. Prince H.E., Kleinman S., Czaplicki C., John J., Williams A.E. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. J. Acquir. Immune Defic. Syndr. 3:(5):1990;525-530.
34. Turman M.A., Yabe T., McSherry C., Bach F.H., Houchins J.P. Characterization of a novel gene (NKG7) on human chromosome 19 that is expressed in natural killer cells and T cells. Hum. Immunol. 36:(1):1993;34-40.
35. van Belzen N., Diesveld M.P., van der Made A.C., Nozawa Y., Dinjens W.N., Vlietstra R., Trapman J., Bosman F.T. Identification of mRNAs that show modulated expression during colon carcinoma cell differentiation. Eur. J. Biochem. 234:(3):1995;843-848.
36. von Stein O.D., Thies W.G., Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res. 25:(13):1997;2598-2602.
37. + T lymphocytes suppresses HIV replication. Immunology. 66:1989;628-630.
38. Walker C.M., Moody D.J., Stites D.P., Levy J.A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 234:1986;1563-1566.
39. Wan J.S., Sharp S.J., Poirier G.M., Wagaman P.C., Chambers J., Pyati J., Hom Y.L., Galindo J.E., Huvar A., Peterson P.A., Jackson M.R., Erlander M.G. Cloning differentially expressed mRNAs. Nat. Biotechnol. 14:(13):1996;1685-1691.
40. + lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cell. Immunol. 128:1990;628-634.